RAPH Raphael Pharmaceutical Inc.

Fundamentals / CIK 0001415397 / USD

Raphael Pharmaceutical Inc. reported $7.0K in total assets and a net loss of $980K through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RAPH in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$3.14MFY 2020 Net Income: -$718K2020FY 2021 Net Income: -$1.62M2021FY 2022 Net Income: -$3.36M2022FY 2023 Net Income: -$1.34M2023FY 2024 Net Income: -$1.52M2024FY 2025 Net Income: -$1.28M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $631K $776K $569K $1.18M $776K $461K
Operating Income -$1.25M -$1.51M -$1.33M -$3.32M -$1.63M -$706K
Net Income -$1.28M -$1.52M -$1.34M -$3.36M -$1.62M -$718K
Basic EPS $0.07 $0.08 $0.08 $0.23 $0.14 $0.07
Diluted EPS $0.07 $0.08 $0.08 $0.23 $0.14 $0.07
Basic Shares Outstanding 19.6M 18.7M 16.7M 14.3M 11.2M 9.5M
Diluted Shares Outstanding 19.6M 18.7M 16.7M 14.3M 11.2M 9.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Research & Development $40K $37K $345K $73K $141K $72K $211K $162K
Operating Income -$199K -$223K -$254K -$251K -$315K -$425K -$394K -$319K
Interest Expense -- $3.0K -- -- -- -- -- --
Net Income -$223K -$229K -$273K -$255K -$322K -$429K -$395K -$326K
Basic EPS $0.01 $0.01 -- $0.01 $0.02 $0.02 -- $0.01
Diluted EPS $0.01 $0.01 -- $0.01 $0.02 $0.02 -- $0.01
Basic Shares Outstanding 20.2M 20.2M -- 19.6M 19.6M 19.6M -- 18.7M
Diluted Shares Outstanding 20.2M 20.2M -- 19.6M 19.6M 19.6M -- 18.7M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents -- $19K $230K $288K $153K $95K
Cash & Short-Term Investments -- $19K $230K $288K $153K $95K
Accounts Receivable, Net $2.0K $2.0K -- -- -- --
Other Current Assets $6.0K $6.0K $7.0K $43K $269K $228K
Total Current Assets $51K $25K $237K $331K $422K $323K
Property, Plant & Equipment, Net $2.0K $2.0K $2.0K -- -- --
Intangible Assets -- -- $2.0K $2.0K -- --
Total Non-Current Assets $2.0K $2.0K $2.0K $2.0K $0 $0
Total Assets $53K $27K $239K $333K $422K $323K
Accounts Payable $163K $125K $69K $72K $107K $9.0K
Short-Term Debt -- $41K -- -- -- $357K
Total Current Liabilities $1.49M $769K $132K $227K $294K $366K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0
Total Liabilities $1.49M $769K $132K $227K $294K $366K
Total Debt (incl. Leases) -- $41K -- -- -- $357K
Common Stock $202K $187K $185K $157K $130K $95K
Retained Earnings -$10.17M -$8.89M -$7.37M -$6.03M -$2.67M -$1.04M
Total Stockholders' Equity -$1.43M -$742K $107K $106K $128K -$43K
Total Equity -$1.43M -$742K $107K $106K $128K -$43K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents -- -- -- -- $20K $50K $19K $40K
Cash & Short-Term Investments -- -- -- -- $20K $50K $19K $40K
Accounts Receivable, Net -- -- $2.0K -- -- -- $2.0K --
Other Current Assets $5.0K -- $6.0K $2.0K $8.0K $41K $6.0K $9.0K
Total Current Assets $6.0K $1.0K $51K $5.0K $28K $91K $25K $49K
Property, Plant & Equipment, Net $1.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K
Total Non-Current Assets $1.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K
Total Assets $7.0K $3.0K $53K $7.0K $30K $93K $27K $51K
Accounts Payable -- -- $163K -- -- -- $125K --
Short-Term Debt -- -- -- -- -- -- $41K --
Total Current Liabilities $1.89M $1.67M $1.49M $1.27M $1.08M $827K $769K $667K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $1.89M $1.67M $1.49M $1.27M $1.08M $827K $769K $667K
Total Debt (incl. Leases) -- -- -- -- -- -- $41K --
Common Stock $202K $202K $202K $196K $196K $9.0K $187K $187K
Retained Earnings -$10.62M -$10.40M -$10.17M -$9.89M -$9.64M -$9.32M -$8.89M -$8.43M
Total Stockholders' Equity -$1.89M -$1.66M -$1.43M -$1.26M -$1.05M -$734K -$742K -$616K
Total Equity -$1.89M -$1.66M -$1.43M -$1.26M -$1.05M -$734K -$742K -$616K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$1.28M -$1.52M -$1.34M -$3.36M -$1.62M -$718K
Stock-Based Compensation $245K $350K $200K $2.29M -- --
Change in Payables -- -- -$190K $102K $234K --
Operating Cash Flow -$210K -$532K -$1.20M -$759K -$1.42M -$779K
Capital Expenditure -- -- -- -$2.0K -- --
Free Cash Flow -- -- -- -$761K -- --
Investing Cash Flow -- -- -- -$2.0K -- --
Common Stock Issued $243K $280K $1.15M -- -- --
Financing Cash Flow $236K $321K $1.15M $896K $1.48M $824K
Net Change in Cash $26K -$211K -$58K $135K $58K $45K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$223K -$229K -$273K -$255K -$322K -$429K -$395K -$326K
Stock-Based Compensation -- -- $1.0K $39K $8.0K $197K -- --
Change in Payables -- -- -- -- -- -- -- $249K
Operating Cash Flow $0 -$44K $46K -$17K -$30K -$209K -$62K -$80K
Common Stock Issued -- -- $3.0K $0 $0 $240K $0 $0
Financing Cash Flow -- -- -$4.0K $0 $0 $240K $41K $0
Net Change in Cash $0 -$44K $42K -$17K -$30K $31K -$21K -$80K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -- -- -1256.1% -3167.9% -1268.8% --
Return on Assets (ROA) -2413.2% -5625.9% -562.3% -1008.4% -384.8% -222.3%
Current Ratio 0.03x 0.03x 1.80x 1.46x 1.44x 0.88x
Quick Ratio -- 0.03x 1.74x 1.27x 0.52x 0.26x
EPS Growth (YoY) -12.5% 0.0% -65.2% +64.3% +100.0% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Return on Assets (ROA) -14000.0% -35966.7% -2413.2% -20014.3% -4906.7% -1503.2% -5625.9% -2082.4%
Current Ratio 0.00x 0.00x 0.03x 0.00x 0.03x 0.11x 0.03x 0.07x
Quick Ratio -- -- -- -- 0.02x 0.06x 0.03x 0.06x
Operating Income Growth (YoY) -- -- -- -- -- -- -632.4% --
Net Income Growth (YoY) -- -- -- -- -- -- -737.1% --
EPS Growth (YoY) -50.0% -50.0% -- 0.0% +100.0% -33.3% -- -75.0%
Source: SEC EDGAR CompanyFacts (CIK 0001415397) · from September 30, 2020 Data through June 30, 2026 · synced Nov 21, 2026, 05:01 UTC · Open in terminal